Cargando…
Calreticulin Fragment 39-272 Promotes B16 Melanoma Malignancy through Myeloid-Derived Suppressor Cells In Vivo
Calreticulin (CRT), a multifunctional Ca(2+)-binding glycoprotein mainly located in the endoplasmic reticulum, is a tumor-associated antigen that has been shown to play protective roles in angiogenesis suppression and anti-tumor immunity. We previously reported that soluble CRT (sCRT) was functional...
Autores principales: | He, Xiao-Yan, Gong, Fang-Yuan, Chen, Yong, Zhou, Zhe, Gong, Zheng, Gao, Xiao-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643410/ https://www.ncbi.nlm.nih.gov/pubmed/29075268 http://dx.doi.org/10.3389/fimmu.2017.01306 |
Ejemplares similares
-
Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen-Specific T Lymphocyte Responses against Melanoma
por: Gong, Zheng, et al.
Publicado: (2022) -
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma
por: Sun, Steven H., et al.
Publicado: (2021) -
Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity
por: Schroeter, Andreas, et al.
Publicado: (2022) -
Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019) -
The many faces of parasite calreticulin
por: Esperante, Diego, et al.
Publicado: (2023)